Inhibition of Myocardial Apoptosis by Ischaemic and Beta-Adrenergic Preconditioning is Dependent on p38 MAPK

By Moolman Johannes   Hartley Shahiem   Wyk Johanna   Marais Erna   Lochner Amanda  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 1, 2006-02 ,pp. : 13-25

Springer Publishing Company

Access to resources Recommend Favorite

Analyzing the anti-ischemia–reperfusion injury effects of ginsenoside Rb1 mediated through the inhibition of p38α MAPK

By Li Gonghao   Qian Wenhao   Zhao Changyun  

Canadian Journal of Physiology and Pharmacology, Vol. 94, Iss. 1, 2016-01 ,pp. : 97-103

NRC Research Press

Access to resources Recommend Favorite

p38 MAPK: A Potential Target of Chronic Pain

By  

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-01 ,pp. : 4405-4418

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of the joint-protective effects of p38 MAPK inhibitors in rodent arthritis

By Mbalaviele Gabriel   Monahan Joseph B  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 2, 2008-02 ,pp. : 163-172

Informa Healthcare

Access to resources Recommend Favorite

p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 867-874

Bentham Science Publishers

Access to resources Recommend Favorite